MicroRNA-138 is a Prognostic Biomarker for Triple-Negative Breast Cancer and Promotes Tumorigenesis via TUSC2 repression

Breast cancer manifests as a spectrum of subtypes with distinct molecular signatures, and different responses to treatment. Of these subtypes, triple-negative breast cancer (TNBC) has the worst prognoses and limited therapeutic options. Here we report aberrant expression of microRNA-138 (miR-138) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Nama, Srikanth, Muhuri, Manish, Di Pascale, Federica, Quah, Shan, Aswad, Luay, Fullwood, Melissa, Sampath, Prabha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722084/
https://www.ncbi.nlm.nih.gov/pubmed/31481748
http://dx.doi.org/10.1038/s41598-019-49155-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722084/
https://www.ncbi.nlm.nih.gov/pubmed/31481748
http://dx.doi.org/10.1038/s41598-019-49155-4

Ejemplares similares